Here is evidence that metformin, especially at high doses and for long periods, is associated with increased risk for neurodegenerative diseases and dementia.
Biogen and Sage Terminate Development of SAGE-324 Following Disappointing Phase 2 Data
Episode 119: Utilizing the Syn-One Test to Diagnose Parkinson Disease
New FNIH Initiative Looks to Expedite Parkinson Disease Diagnosis Through Validated Biomarkers
Special Episode: FDA Approves Donanemab for Early Symptomatic Alzheimer Disease
This Week on NeurologyLive® — July 22, 2024
NeurologyLive® Brain Games: July 21, 2024